• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过苯硼酸功能化聚酰胺-胺介导的治疗性 DNA 酶 Dz13 的递送来抑制肿瘤细胞的增殖和迁移。

Inhibition of proliferation and migration of tumor cells through phenylboronic acid-functionalized polyamidoamine-mediated delivery of a therapeutic DNAzyme Dz13.

机构信息

Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, People's Republic of China.

出版信息

Int J Nanomedicine. 2019 Aug 9;14:6371-6385. doi: 10.2147/IJN.S211744. eCollection 2019.

DOI:10.2147/IJN.S211744
PMID:31496692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6691943/
Abstract

BACKGROUND

The phenylboronic acid-functionalized polyamidoamine (PP) was employed as a gene carrier for Dz13 delivery, inducing an obvious anticancer response.

MATERIALS AND METHODS

The Dz13 condensation ability of PP was evaluated through gel retardation assay. The cellular uptake mechanism of PP/Dz13 nanoparticles was studied using confocal laser scanning microscope and flow cytometer. The inhibition ability of cell proliferation, migration and invasion was investigated through MTT assay, flow cytometry, wound healing and Transwell migration assays, using hepatocarcinoma cell line HepG2 as a model. Finally, Western blotting analysis was used to detect the signaling pathway associated with the inhibition of cell apoptosis and migration induced by Dz13 delivery.

RESULTS

The carrier PP could efficiently condense Dz13 into stable nanoparticles at mass ratios of >1.5. The hydrodynamic diameter and zeta potential of PP/Dz13 nanoparticles were measured to be 204.77 nm and +22.00 mV at a mass ratio of 10.0, respectively. The nanoparticles could realize an efficient cellular uptake in sialic acid-dependent endocytosis manner. Moreover, the nanoparticles exhibited an obvious antiproliferation effect through the induction of cell apoptosis and cell cycle arrest due to the cleavage of mRNA. Besides, the suppression of cell migration and invasion could be achieved after the PP/Dz13 transfection, attributing to the decreased expression level of and .

CONCLUSION

The PP provided a potential delivery system to achieve the tumor-targeting gene therapy.

摘要

背景

苯硼酸功能化聚酰胺胺(PP)被用作 Dz13 的基因载体,诱导明显的抗癌反应。

材料与方法

通过凝胶阻滞实验评估 PP 对 Dz13 的凝聚能力。使用共聚焦激光扫描显微镜和流式细胞仪研究 PP/Dz13 纳米颗粒的细胞摄取机制。通过 MTT 测定、流式细胞术、划痕愈合和 Transwell 迁移实验,以肝癌细胞系 HepG2 为模型,研究细胞增殖、迁移和侵袭的抑制能力。最后,通过 Western blot 分析检测与 Dz13 递送诱导的细胞凋亡和迁移抑制相关的信号通路。

结果

载体 PP 可以在质量比大于 1.5 时有效地将 Dz13 凝聚成稳定的纳米颗粒。在质量比为 10.0 时,PP/Dz13 纳米颗粒的水动力直径和 zeta 电位分别为 204.77nm 和+22.00mV。纳米颗粒可以通过依赖唾液酸的内吞作用实现有效的细胞摄取。此外,由于 mRNA 的切割,纳米颗粒通过诱导细胞凋亡和细胞周期停滞表现出明显的抗增殖作用。此外,PP/Dz13 转染后可以抑制细胞迁移和侵袭,这归因于 和 的表达水平降低。

结论

PP 提供了一种潜在的递送系统,可实现肿瘤靶向基因治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/a67037e5a819/IJN-14-6371-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/0301fa7aa1c6/IJN-14-6371-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/b7f21727a784/IJN-14-6371-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/ba726795a078/IJN-14-6371-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/c75e8146a2d5/IJN-14-6371-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/01750ec1429a/IJN-14-6371-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/5baa73650fc8/IJN-14-6371-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/cb53432e1125/IJN-14-6371-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/6409edf57056/IJN-14-6371-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/2a3c887d58ad/IJN-14-6371-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/821b7b196891/IJN-14-6371-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/c0866f3927ba/IJN-14-6371-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/a67037e5a819/IJN-14-6371-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/0301fa7aa1c6/IJN-14-6371-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/b7f21727a784/IJN-14-6371-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/ba726795a078/IJN-14-6371-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/c75e8146a2d5/IJN-14-6371-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/01750ec1429a/IJN-14-6371-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/5baa73650fc8/IJN-14-6371-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/cb53432e1125/IJN-14-6371-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/6409edf57056/IJN-14-6371-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/2a3c887d58ad/IJN-14-6371-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/821b7b196891/IJN-14-6371-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/c0866f3927ba/IJN-14-6371-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb5/6691943/a67037e5a819/IJN-14-6371-g0012.jpg

相似文献

1
Inhibition of proliferation and migration of tumor cells through phenylboronic acid-functionalized polyamidoamine-mediated delivery of a therapeutic DNAzyme Dz13.通过苯硼酸功能化聚酰胺-胺介导的治疗性 DNA 酶 Dz13 的递送来抑制肿瘤细胞的增殖和迁移。
Int J Nanomedicine. 2019 Aug 9;14:6371-6385. doi: 10.2147/IJN.S211744. eCollection 2019.
2
Phenylboronic Acid-Modified Polyamidoamine Mediated the Transfection of Polo-Like Kinase-1 siRNA to Achieve an Anti-Tumor Efficacy.苯硼酸修饰的聚酰胺-胺介导 Polo 样激酶-1 siRNA 的转染以实现抗肿瘤功效。
Int J Nanomedicine. 2021 Dec 13;16:8037-8048. doi: 10.2147/IJN.S329433. eCollection 2021.
3
Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer.递送靶向极光激酶A的脱氧核酶以抑制人前列腺癌的增殖和迁移。
Int J Nanomedicine. 2015 Sep 9;10:5715-27. doi: 10.2147/IJN.S90559. eCollection 2015.
4
Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery.通过碱基修饰的聚酰胺-胺介导的 p53 递送来抑制细胞增殖和迁移。
Int J Nanomedicine. 2018 Mar 6;13:1297-1311. doi: 10.2147/IJN.S146917. eCollection 2018.
5
Phenylboronic acid-modified polyamidoamine-mediated delivery of short GC rich DNA for hepatocarcinoma gene therapy.苯硼酸修饰的聚酰胺-胺介导的富含 GC 的短 DNA 递用于肝癌基因治疗。
Biomater Sci. 2019 Aug 1;7(8):3348-3358. doi: 10.1039/c9bm00394k. Epub 2019 Jun 20.
6
Phenylboronic acid-functionalized polyamidoamine-mediated miR-34a delivery for the treatment of gastric cancer.苯硼酸功能化聚酰胺-胺介导的 miR-34a 递送用于胃癌治疗。
Biomater Sci. 2019 Mar 26;7(4):1632-1642. doi: 10.1039/c8bm01385c.
7
Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents.靶向c-Jun的脱氧核酶对啮齿动物实体瘤生长和血管生成的影响。
J Natl Cancer Inst. 2004 May 5;96(9):683-96. doi: 10.1093/jnci/djh120.
8
Phenylboronic acid-functionalized polyamidoamine-mediated Bcl-2 siRNA delivery for inhibiting the cell proliferation.苯硼酸功能化聚酰胺-胺介导的 Bcl-2 siRNA 递送抑制细胞增殖。
Colloids Surf B Biointerfaces. 2016 Oct 1;146:318-25. doi: 10.1016/j.colsurfb.2016.06.034. Epub 2016 Jun 20.
9
Sequence-related off-target effect of Dz13 against human tumor cells and safety in adult and fetal mice following systemic administration.Dz13对人类肿瘤细胞的序列相关脱靶效应及全身给药后在成年和胎鼠中的安全性。
Oligonucleotides. 2010 Apr;20(2):51-60. doi: 10.1089/oli.2009.0219.
10
The DNAzymes Rs6, Dz13, and DzF have potent biologic effects independent of catalytic activity.脱氧核酶Rs6、Dz13和DzF具有独立于催化活性的强大生物学效应。
Oligonucleotides. 2006 Winter;16(4):297-312. doi: 10.1089/oli.2006.16.297.

引用本文的文献

1
A promising nucleic acid therapy drug: DNAzymes and its delivery system.一种有前景的核酸治疗药物:脱氧核酶及其递送系统。
Front Mol Biosci. 2023 Sep 11;10:1270101. doi: 10.3389/fmolb.2023.1270101. eCollection 2023.
2
Phenylboronic-acid-based Functional Chemical Materials for Fluorescence Imaging and Tumor Therapy.用于荧光成像和肿瘤治疗的基于苯硼酸的功能化学材料。
ACS Omega. 2022 Jan 12;7(3):2520-2532. doi: 10.1021/acsomega.1c06558. eCollection 2022 Jan 25.
3
Phenylboronic Acid-Modified Polyamidoamine Mediated the Transfection of Polo-Like Kinase-1 siRNA to Achieve an Anti-Tumor Efficacy.

本文引用的文献

1
Supercritical Fluid-Assisted Fabrication of Indocyanine Green-Encapsulated Silk Fibroin Nanoparticles for Dual-Triggered Cancer Therapy.用于双触发癌症治疗的超临界流体辅助制备包裹吲哚菁绿的丝素蛋白纳米颗粒
ACS Biomater Sci Eng. 2018 Oct 8;4(10):3487-3497. doi: 10.1021/acsbiomaterials.8b00705. Epub 2018 Sep 10.
2
Overcoming Multidrug Resistance through the Synergistic Effects of Hierarchical pH-Sensitive, ROS-Generating Nanoreactors.通过分级pH敏感、产生活性氧的纳米反应器的协同效应克服多药耐药性
ACS Biomater Sci Eng. 2017 Oct 9;3(10):2431-2442. doi: 10.1021/acsbiomaterials.7b00569. Epub 2017 Sep 22.
3
Phenylboronic acid-modified polyamidoamine-mediated delivery of short GC rich DNA for hepatocarcinoma gene therapy.
苯硼酸修饰的聚酰胺-胺介导 Polo 样激酶-1 siRNA 的转染以实现抗肿瘤功效。
Int J Nanomedicine. 2021 Dec 13;16:8037-8048. doi: 10.2147/IJN.S329433. eCollection 2021.
4
Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment.核仁素靶向 AS1411 适体修饰的胶束共载多柔比星和 miR-519c 提高肝癌治疗疗效。
Int J Nanomedicine. 2021 Mar 30;16:2569-2584. doi: 10.2147/IJN.S304526. eCollection 2021.
5
Fabrication Of Dual pH/redox-Responsive Lipid-Polymer Hybrid Nanoparticles For Anticancer Drug Delivery And Controlled Release.制备双 pH/氧化还原响应性脂质-聚合物杂化纳米粒子用于抗癌药物输送和控制释放。
Int J Nanomedicine. 2019 Oct 3;14:8001-8011. doi: 10.2147/IJN.S226798. eCollection 2019.
苯硼酸修饰的聚酰胺-胺介导的富含 GC 的短 DNA 递用于肝癌基因治疗。
Biomater Sci. 2019 Aug 1;7(8):3348-3358. doi: 10.1039/c9bm00394k. Epub 2019 Jun 20.
4
Dermal delivery of therapeutic DNAzymes via chitosan hydrogels.壳聚糖水凝胶经皮递送达治疗性 DNA 酶。
Int J Pharm. 2019 May 30;563:208-216. doi: 10.1016/j.ijpharm.2019.04.005. Epub 2019 Apr 3.
5
A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated gene delivery for achieving antitumor efficacy in prostate cancer.一种通过酶化学合成的胆固醇-g-聚(胺-co-酯)介导的基因递送来实现前列腺癌的抗肿瘤疗效。
Int J Nanomedicine. 2019 Feb 13;14:1149-1161. doi: 10.2147/IJN.S191905. eCollection 2019.
6
Deoxyribozymes as Catalytic Nanotherapeutic Agents.脱氧核酶作为催化纳米治疗剂。
Cancer Res. 2019 Mar 1;79(5):879-888. doi: 10.1158/0008-5472.CAN-18-2474. Epub 2019 Feb 13.
7
Phenylboronic acid-functionalized polyamidoamine-mediated miR-34a delivery for the treatment of gastric cancer.苯硼酸功能化聚酰胺-胺介导的 miR-34a 递送用于胃癌治疗。
Biomater Sci. 2019 Mar 26;7(4):1632-1642. doi: 10.1039/c8bm01385c.
8
Tetrahedral DNA Nanostructure-Delivered DNAzyme for Gene Silencing to Suppress Cell Growth.四面体 DNA 纳米结构递呈的 DNA 酶用于基因沉默以抑制细胞生长。
ACS Appl Mater Interfaces. 2019 Feb 20;11(7):6850-6857. doi: 10.1021/acsami.8b22444. Epub 2019 Feb 7.
9
Overcoming multidrug resistance through inhalable siRNA nanoparticles-decorated porous microparticles based on supercritical fluid technology.基于超临界流体技术的吸入型 siRNA 纳米粒修饰多孔微球克服多药耐药性。
Int J Nanomedicine. 2018 Aug 15;13:4685-4698. doi: 10.2147/IJN.S169399. eCollection 2018.
10
Identification of natural compounds targeting Annexin A2 with an anti-cancer effect.鉴定具有抗癌作用的靶向膜联蛋白 A2 的天然化合物。
Protein Cell. 2018 Jun;9(6):568-579. doi: 10.1007/s13238-018-0513-z. Epub 2018 Mar 5.